Context Therapeutics Reports First Quarter 2024 Operating and Financial Results


Announced FDA clearance of IND application for a Phase 1 clinical trial of CTIM-76

Follow this link:
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

Related Posts